Gynecomasti Treatment (Male Breast Reduction)
Gynecomastia is a common clinical condition characterized by the benign proliferation of glandular (breast tissue) and adipose (fatty) components in males, leading to a feminine breast appearance. During its developmental onset, the condition frequently exhibits asymmetrical progression, causing one breast to expand significantly more than the other. While gynecomastia predominantly surfaces during the profound hormonal fluctuations of adolescence (pubertal gynecomastia), it can also manifest as physiological anomalies during infancy or senility (the elderly phase).
This structural alteration frequently triggers severe psychological distress, social anxiety, and a loss of self-confidence in male patients. It can present either as a true hypertrophy of firm glandular tissue or a pseudo-gynecomastia (lipomasti) driven strictly by localized fat accumulation. At Prof. Dr. İsmail Küçüker Clinic, advanced ultrasound screening is utilized to map out the exact tissue configuration before surgery, allowing us to plan a virtually scarless, customized architectural correction.
What Causes Gynecomastia? Primary Etiological Factors
The overwhelming majority of gynecomastia cases represent strictly benign (non-cancerous) tissue overgrowths. The core physiological trigger is a relative androgen-to-estrogen imbalance, where circulating estrogen levels override masculine testosterone levels. The primary medical and systemic causes behind this hormonal shift include:
✦ Pharmacological Side Effects: Chronic use of certain medications, such as specific antidepressants, antibiotics, chemotherapy regimens, prostate cancer therapies, cardiovascular drugs, and anti-ulcer medications, can trigger tissue growth as a secondary reaction.
✦ Anabolic Steroids and Substances: Non-medical consumption of performance-enhancing anabolic steroids for muscle mass accumulation, along with certain illegal substances, severely disrupts the endocrine axis.
✦ Chronic Systemic Conditions: Significant underlying medical conditions, including hepatic failure (liver cirrhosis), advanced kidney disease, thyroid imbalances (hyperthyroidism), generalized obesity, and congenital metabolic syndromes.
✦ Endocrine Tumoral Pathologies: Rare adrenal gland, pituitary gland, or testicular tumors, as well as lung cancer, which active abnormal systemic hormone secretion.
Transient gynecomastia in newborns is triggered by maternal estrogen crossing the placental barrier; this resolves spontaneously as the hormones clear the infant's system. Critically, there is no direct pathological link between gynecomastia and male breast cancer, which remains exceptionally rare globally. However, to ensure absolute oncolojik safety, our clinic carries out rigid pre-operative diagnostics to eliminate any anomalous risks.